Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11912997
RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use
granted -
US 11912778
Methods of engineering transferrin receptor binding polypeptides
granted -
US 11912780
Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies
granted -
US 11912762
Method of treating osteoarthritis by administering an anti-connexin 43 antibody
granted -
US 11912682
Isoindolinone compounds
granted -
US 11912714
Spiropyrrolidine derived antiviral agents
granted -
US 11912695
Benzodiazepine derivatives as RSV inhibitors
granted -
US 11910788
Mouse having a humanized cluster of differentiation 47 gene
granted -
US 11911368
Method of treatment of CNS disorders
granted -
US 11911359
Stimulation of an immune response by cationic lipids
granted -
US 11911446
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
granted -
US 11913012
Cardiac cell reprogramming with myocardin and ASCL1
granted -
US 11912750
GDNF fusion polypeptides and methods of use thereof
granted -
US 11911434
Stable antibody-drug conjugate, preparation method therefor, and use thereof
granted -
US 11912758
Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel
granted -
US 11911515
Extended release compositions comprising pyridostigmine
granted -
US 11911484
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted -
WO 2024039256
RÉGIMES THÉRAPEUTIQUES POUR LA MALADIE DE PARKINSON
granted -
US 11903994
Dosing regimens
granted -
US 11904006
Poly(diaminosulfide) particle-based vaccine
granted -
US 11903930
Methods and compositions for treatment of epileptic disorders
granted -
US 11903973
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11903920
Cannabinoid formulation: production method and use
granted -
US 11903966
Intracellular genomic transplant and methods of therapy
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.